Correspondence 0001104659-24-067857 from Structure Therapeutics Inc. (GPCR) (CIK 0001888886) (GPCR)
Structure Therapeutics Inc. (GPCR) (CIK 0001888886)
Date: June 3, 2024 · CIK: 0001888886 · Accession: 0001104659-24-067857
AI Filing Summary & Sentiment
File numbers found in text: 333-279915
Letter
June 3, 2024
Goldman Sachs & Co. LLC
200 West Street
New York, NY 10282
Morgan Stanley & Co. LLC
1585 Broadway
New York, NY 10036
Jefferies LLC
520 Madison Avenue
New York, New York 10022
Leerink Partners LLC
53 State Street, 40th Floor
Boston, MA 02109
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky
Re: Structure Therapeutics Inc.
Registration Statement on Form S-1
(File No. 333-279915)
Acceleration Request
Requested Date: June 5, 2024
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), we, as representatives of the several underwriters (the “Representatives”), hereby join in the request of Structure Therapeutics Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Registrant”), that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time on June 5, 2024, or as soon thereafter as practicable, or at such other time as the Registrant or its outside counsel, Cooley LLP, request by telephone that such Registration Statement be declared effective.
Pursuant to Rule 460 under the Securities Act, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus, to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.
We, the undersigned Representatives, have and will, and we have been informed by the participating underwriters that they have and will, comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, in connection with the proposed offering.
[Remainder of page intentionally left blank]
Very truly yours,
Acting severally on behalf of themselves and the several underwriters
Show Raw Text
CORRESP
1
filename1.htm
June 3, 2024
Goldman Sachs & Co. LLC
200 West Street
New York, NY 10282
Morgan Stanley & Co. LLC
1585 Broadway
New York, NY 10036
Jefferies LLC
520 Madison Avenue
New York, New York 10022
Leerink Partners LLC
53 State Street, 40th Floor
Boston, MA 02109
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky
Re: Structure Therapeutics Inc.
Registration Statement on Form S-1
(File
No. 333-279915)
Acceleration Request
Requested Date: June 5, 2024
Requested Time: 4:00
P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule
461 of the Securities Act of 1933, as amended (the “Securities Act”),
we, as representatives of the several underwriters (the “Representatives”),
hereby join in the request of Structure Therapeutics Inc., an exempted company with limited liability
incorporated under the laws of the Cayman Islands (the “Registrant”), that the effectiveness of the above-captioned
Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time on June 5, 2024,
or as soon thereafter as practicable, or at such other time as the Registrant or its outside counsel, Cooley LLP, request by telephone
that such Registration Statement be declared effective.
Pursuant
to Rule 460 under the Securities Act, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary
prospectus, to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.
We, the undersigned Representatives,
have and will, and we have been informed by the participating underwriters that they have and will, comply with the requirements of Rule
15c2-8 under the Securities Exchange Act of 1934, as amended, in connection with the proposed offering.
[Remainder of page
intentionally left blank]
Very truly yours,
Acting severally on behalf of themselves and the several underwriters
GOLDMAN SACHS & CO. LLC
MORGAN STANLEY & CO. LLC
JEFFERIES LLC
LEERINK PARTNERS LLC
GOLDMAN SACHS & CO. LLC
By:
/s/ Lyla Bibi Maduri
Name:
Lyla Bibi Maduri
Title:
Managing Director
MORGAN STANLEY & CO. LLC
By:
/s/ Chirag D. Surti
Name:
Chirag D. Surti
Title:
Executive Director
JEFFERIES LLC
By:
/s/ Matthew Kim
Name:
Matthew Kim
Title:
Managing Director
LEERINK PARTNERS LLC
By:
/s/ Sean Pitt
Name:
Sean Pitt
Title:
Senior Managing Director
[Signature Page to Underwriters’ Acceleration
Request Letter]